Latest Articles
Tobin J Arthur • February 27, 2014

It’s like a broken record around angelMD….we constantly advocate that investors stick to that which they know. In our case, the investors are physicians and they know healthcare. For an interesting perspective on this very theme, read Tim Worstall’s post from PandoDaily in which he talks about the fact that small nuances in ones understanding ...
Read more

LinkedInTwitterFacebook
Team angelMD • February 26, 2014

Dr. Steven Charlap recently wrote a piece for The Atlantic which was subsequently picked up by MedCity News. In his piece he blames “fee for service” for the demise of his preventative health venture.  Specifically, he blames the lack of other providers willing to refer, the lack of payers willing to reimburse, and the lack ...
Read more

LinkedInTwitterFacebook
Tobin J Arthur • February 20, 2014

All the talk about General Solicitation and the resulting media coverage has focused on what it means for the ability of startups to raise capital. The focus of the discussion is misplaced. In an investment marketplace the investors are the drivers…not the startups. Until investors feel THEY have an edge by engaging in a crowd-funding ...
Read more

LinkedInTwitterFacebook
Tobin J Arthur • February 18, 2014

In the MedCity story entitled: “Looks like ‘general solicitation’ is a flop so far for healthcare startups” the author frames “general solicitation” as not having met expectations of the crowd, as it were.  This statement is true because the hype and misinformation surrounding the changes in general solicitation ignored the facts on the ground.  The ...
Read more

LinkedInTwitterFacebook
Team angelMD •

San Francisco, CA (PRWEB) February 18, 2014  —  angelMD, the funding platform that connects physicians and leading medical startups, today announced that CEO Tobin Arthur will be participating on a crowd-funding panel as part  of the Texas Life Science Venture Forum. “Texas is one of the strongest healthcare innovation and care delivery markets in the ...
Read more

LinkedInTwitterFacebook